Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: Historical cohort study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chida, Shoma ^a   Fujita, Yoshikuni ^a   Ogawa, Akifumi ^a   Hayashi, Akinori ^a   Ichikawa, Raishi ^a   Kamata, Yuji ^a   Takeuchi, Akihiro ^a   Takano, Koji ^a   Shichiri, Masayoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HUMAN SERUM ALBUMIN;

AGED; ALBUMINURIA; BLOOD; COHORT ANALYSIS; COMPLICATION; DISEASE EXACERBATION; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; URINE;

AGED; ALBUMINURIA; COHORT STUDIES; CREATININE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ROC CURVE; SERUM ALBUMIN, HUMAN;

EID: 84971216549     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26380     Document Type: Article

References (43)

1. Mogensen C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310, 356-360 (1984
2. Mogensen C. E., & Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311, 89-93 (1984
3. Viberti G. C., et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 319, 1430-1432 (1982
4. Damsgaard E. M., Froland A., Jorgensen O. D., & Mogensen C. E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300, 297-300 (1990
5. Gerstein H. C., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286, 421-426 (2001
6. Wachtell K., et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139, 901-906 (2003
7. Mancia G., et al. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25, 1105-1187 (2007
8. Sacks D. B., et al. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 34, 1419-1423 (2011
9. The Japan Diabetes Society. Evidence-based practice guideline for the treatment for diabetes in Japan 2013. 97-113 (Nanko-do, 2013
10. Roshan B., & Stanton R. C. A story of microalbuminuria and diabetic nephropathy. J Nephropathol 2, 234-240 (2013
11. Perkins B. A., et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348, 2285-2293 (2003
12. De Boer I. H., et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171, 412-420 (2011
13. Vaidya V. S., et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase. Kidney Int 79, 464-470 (2011
14. Kramer H. J., Nguyen Q. D., Curhan G., & Hsu C. Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289, 3273-3277 (2003
15. MacIsaac R. J., et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 27, 195-200 (2004
16. Perkins B. A., Ficociello L. H., Roshan B., Warram J. H., & Krolewski A. S. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 77, 57-64 (2010
17. Mottl A. K., et al. Normoalbuminuric diabetic kidney disease in the US population. J Diabetes Complications 27, 123-127 (2013
18. Moriya T., et al. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes. Kidney Int 81, 486-493 (2012
19. Shimizu M., et al. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care 36, 3655-3662 (2013
20. Klausen K., et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110, 32-35 (2004
21. Arnlov J., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112, 969-975 (2005
22. Babazono T., et al. Higher levels of urinary albumin excretion within the normal range predict faster decline in glomerular filtration rate in diabetic patients. Diabetes Care 32, 1518-1520 (2009
23. Forman J. P., & Brenner B. M. ?Hypertension? and ?microalbuminuria?: the bell tolls for thee. Kidney Int 69, 22-28 (2006
24. Mathiesen E. R., Ronn B., Jensen T., Storm B., & Deckert T. Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 39, 245-249 (1990
25. Zoppini G., et al. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol 7, 401-408 (2012
26. Lorenzo V., Saracho R., Zamora J., Rufino M., & Torres A. Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria. Nephrol Dial Transplant 25, 835-841 (2010
27. Chavers B. M., Bilous R. W., Ellis E. N., Steffes M. W., & Mauer S. M. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 320, 966-970 (1989
28. Steinke J. M., et al. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54, 2164-2171 (2005
29. Mauer M., et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361, 40-51 (2009
30. Fenili D., & Pirovano B. The automation of sediment urinalysis using a new urine flow cytometer (UF-100). Clin Chem Lab Med 36, 909-917 (1998
31. Delanghe J. R., et al. The role of automated urine particle flow cytometry in clinical practice. Clin Chim Acta 301, 1-18 (2000
32. Regeniter A., et al. Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results-a multicenter study. Clin Nephrol 55, 384-392 (2001
33. Manoni F., et al. Urine particle evaluation: a comparison between the UF-1000i and quantitative microscopy. Clin Chem Lab Med 48, 1107-1111 (2010
34. Wang J., Zhang Y., Xu D., Shao W., & Lu Y. Evaluation of the Sysmex UF-1000i for the diagnosis of urinary tract infection. Am J Clin Pathol 133, 577-582 (2010
35. Jiang T., Chen P., Ouyang J., Zhang S., & Cai D. Urine particles analysis: performance evaluation of Sysmex UF-1000i and comparison among urine flow cytometer, dipstick, and visual microscopic examination. Scand J Clin Lab Invest 71, 30-37 (2011
36. Shichiri M., Oowada A., Nishio Y., Tomita K., & Shiigai T. Use of autoanalyser to examine urinary-red-cell morphology in the diagnosis of glomerular haematuria. Lancet 328, 781-782 (1986
37. Shichiri M. Differentiating glomerular and non-glomerular haematuria. Lancet 332, 446-447 (1988
38. Shichiri M., et al. Red-cell-volume distribution curves in diagnosis of glomerular and non-glomerular haematuria. Lancet 331, 908-911 (1988
39. Caramori M. L., Fioretto P., & Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 52, 1036-1040 (2003
40. Retnakaran R., Cull C. A., Thorne K. I., Adler A. I., & Holman R. R. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes 55, 1832-1839 (2006
41. Ninomiya T., et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20, 1813-1821 (2009
42. Molitch M. E., et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33, 1536-1543 (2010
43. Wang Y., Chen X., Song Y., Caballero B., & Cheskin L. J. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73, 19-33 (2008